References
- Gaudineau A. Prévalence, facteurs de risque et morbi-mortalité materno-foetale des troubles de la croissance foetale. J Gynecol Obstet Biol Reprod. 2013;42(8):895–910.
- Clausson B, Gardosi J, Francis A, et al. Perinatal outcome in SGA births defined by customised versus population-based birthweight standards. BJOG. 2001;108(8):830–834.
- Barker DJ. The fetal and infant origins of adult disease. BMJ Clin Res. 1990;301:1111.
- Stock K, Schmid A, Griesmaier E, et al. The impact of being born preterm or small for gestational age on early vascular aging in adolescents. J Pediatr. 2018;201:49–54.e1.
- van Rijn BB, Hoeks LB, Bots ML, et al. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol. 2006;195(3):723–728.
- Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol. 1991;165(5 Pt 1):1408–1412.
- Van Oostwaard MF, Langenveld J, Schuit E, et al. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. Am J Obstet Gynecol. 2015;212(5):624.e1–624.e17.
- Rey E, Garneau P, David M, et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost. 2009;7(1):58–64.
- Vayssière C, Sentilhes L, Ego A, et al. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol. 2015;193:10–18.
- Royal College of Obstetricians and Gynaecologists. The investigation and management of the small-for-gestational-age fetus. guideline, vol. 31. London: RCOG; 2002.
- Mandruzzato G, Antsaklis A, Botet F, et al. Intrauterine restriction (IUGR). J Perinat Med. 2008;36(4):277–281.
- Berks D, Duvekot JJ, Basalan H, et al. Associations between phenotypes of preeclampsia and thrombophilia. Eur J Obstet Gynecol Reprod Biol. 2015;194:199–205.
- Louis-Jacques AF, Maggio L, Romero ST. Prenatal screening for thrombophilias: indications and controversies, an update. Clin Lab Med. 2016;36(2):421–434.
- Baptista FS, Bortolotto MRFL, Bianchini FRM, et al. Can thrombophilia worsen maternal and perinatal outcomes in cases of severe preeclampsia? Pregnancy Hypertens. 2018;11:81–86.
- Redline RW. Placental pathology: a systematic approach with clinical correlations. Placenta. 2008;29:86–91.
- Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol. 2002;5(2):159–164.
- Gogia N, Machin GA. Maternal thrombophilias are associated with specific placental lesions. Pediatr Dev Pathol. 2008;11(6):424–429.
- Aviram R, Biron Shental T, Kidron D. Placental aetiologies of foetal growth restriction: clinical and pathological differences. Early Hum Dev. 2010;86(1):59–63.
- Kovo M, Schreiber L, ben-Haroush A, et al. Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction. Am J Obstet Gynecol. 2010;202(6):561.e1–561.e5.
- Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol. 2007;38(10):1439–1446.
- Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613–622.
- de Vries JI, van Pampus MG, Hague WM, et al. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J Thromb Haemost. 2012;10(1):64–72.
- Rodger MA, Gris JC, de Vries JIP, et al. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials. Lancet. 2016;388(10060):2629–2641.
- Duffett L, Rodger M. LMWH to prevent placenta-mediated pregnancy complications: an update. Br J Haematol. 2015;168(5):619–638.
- Groom KM, David AL. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. Am J Obstet Gynecol. 2018;218(2S):S829–S840.